These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22484807)

  • 1. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors.
    Berger AM; Hertzog M; Geary CR; Fischer P; Farr L
    J Cancer Surviv; 2012 Sep; 6(3):305-14. PubMed ID: 22484807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.
    Berger AM; Wielgus K; Hertzog M; Fischer P; Farr L
    Support Care Cancer; 2010 Jan; 18(1):105-14. PubMed ID: 19381692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal associations of diurnal rest-activity rhythms with fatigue, insomnia, and health-related quality of life in survivors of colorectal cancer up to 5 years post-treatment.
    Chong MY; Frenken KG; Eussen SJPM; Koster A; Pot GK; Breukink SO; Janssen-Heijnen M; Keulen ETP; Bijnens W; Buffart LM; Meijer K; Scheer FAJL; Steindorf K; de Vos-Geelen J; Weijenberg MP; van Roekel EH; Bours MJL
    Int J Behav Nutr Phys Act; 2024 May; 21(1):51. PubMed ID: 38698447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
    Wielgus KK; Berger AM; Hertzog M
    Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
    Sultan A; Choudhary V; Parganiha A
    Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circadian activity rhythms and fatigue in hospitalized children with CNS cancers receiving high-dose chemotherapy.
    Rogers VE; Zhu S; Mandrell BN; Ancoli-Israel S; Liu L; Hinds PS
    Support Care Cancer; 2020 Mar; 28(3):1459-1467. PubMed ID: 31273507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy.
    Liu L; Rissling M; Natarajan L; Fiorentino L; Mills PJ; Dimsdale JE; Sadler GR; Parker BA; Ancoli-Israel S
    Sleep; 2012 Feb; 35(2):237-45. PubMed ID: 22294814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.
    Ancoli-Israel S; Liu L; Marler MR; Parker BA; Jones V; Sadler GR; Dimsdale J; Cohen-Zion M; Fiorentino L
    Support Care Cancer; 2006 Mar; 14(3):201-9. PubMed ID: 16010529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment.
    Roscoe JA; Morrow GR; Hickok JT; Bushunow P; Matteson S; Rakita D; Andrews PL
    Support Care Cancer; 2002 May; 10(4):329-36. PubMed ID: 12029433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.
    Ratcliff CG; Lam CY; Arun B; Valero V; Cohen L
    Psychooncology; 2014 Nov; 23(11):1220-8. PubMed ID: 24706506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of circadian parameters and the clustering of fatigue, depression, and sleep problems in breast cancer survivors: a latent class analysis.
    de Rooij BH; Ramsey I; Clouth FJ; Corsini N; Heyworth JS; Lynch BM; Vallance JK; Boyle T
    J Cancer Surviv; 2023 Oct; 17(5):1405-1415. PubMed ID: 35318570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.
    Ancoli-Israel S; Liu L; Rissling M; Natarajan L; Neikrug AB; Palmer BW; Mills PJ; Parker BA; Sadler GR; Maglione J
    Support Care Cancer; 2014 Sep; 22(9):2535-45. PubMed ID: 24733634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
    Perez EA; Geeraerts L; Suman VJ; Adjei AA; Baron AT; Hatfield AK; Maihle N; Michalak JC; Kuross SA; Kugler JW; Lafky JM; Ingle JN
    Ann Oncol; 2002 Aug; 13(8):1225-35. PubMed ID: 12181246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian activity rhythms and fatigue of adolescent cancer survivors and healthy controls: a pilot study.
    Rogers VE; Mowbray C; Zhu S; Liu L; Ancoli-Israel S; Barr EA; Hinds PS
    J Clin Sleep Med; 2020 Jul; 16(7):1141-1147. PubMed ID: 32267222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study.
    Berger AM; Higginbotham P
    Oncol Nurs Forum; 2000 Oct; 27(9):1443-8. PubMed ID: 11058976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy.
    Berger AM; Farr LA; Kuhn BR; Fischer P; Agrawal S
    J Pain Symptom Manage; 2007 Apr; 33(4):398-409. PubMed ID: 17397701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
    Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
    Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.
    Lengacher CA; Johnson-Mallard V; Post-White J; Moscoso MS; Jacobsen PB; Klein TW; Widen RH; Fitzgerald SG; Shelton MM; Barta M; Goodman M; Cox CE; Kip KE
    Psychooncology; 2009 Dec; 18(12):1261-72. PubMed ID: 19235193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer.
    Yazilitas D; Sendur MA; Karaca H; Ozdemir N; Aksoy S; Berk V; Yazici O; Ozturk B; Ozkan M; Zengin N; Altundag K
    Asian Pac J Cancer Prev; 2015; 16(4):1471-7. PubMed ID: 25743817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective physical and mental markers of self-reported fatigue in women undergoing (neo)adjuvant chemotherapy for early-stage breast cancer.
    Mortimer JE; Waliany S; Dieli-Conwright CM; Patel SK; Hurria A; Chao J; Tiep B; Behrendt CE
    Cancer; 2017 May; 123(10):1810-1816. PubMed ID: 28061004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.